
Carbohydrate Research p. 107 - 115 (1992)
Update date:2022-08-03
Topics:
Ljevakovic
Tomic
Tomasic
The selective pivaloylation (pivaloyl chloride-pyridine) of D-glucopyranose proceeds by two pathways after initial 6-pivaloylation, namely, successive esterification of (a) positions 1, 3, 4, and 2 (major pathway) and (b) positions 2, 1, 4, and 3 (minor pathway). Numerous di- (3 and 4), tri- (5-9), and tetra-pivalates (10-12) have been prepared and characterised. On treatment of the 2,6-dipivalate (4) with rabbit serum or partially purified esterase II, PivO-6 was hydrolysed selectively, whereas the 1,6-dipivalate (3) underwent partial 1 → 2 acyl migration to give 4 and enzymic de-esterification of 3 and 4 occurred simultaneously. The selective pivaloylation (pivaloyl chloride-pyridine) of D-glucopyranose proceeds by two pathways after initial 6-pivaloylation, namely, successive esterification of (a) positions 1, 3, 4, and 2 (major pathway) and (b) positions 2, 1, 4, and 3 (minor pathway). Numerous di- (3 and 4), tri- (5-9), and tetra-pivalates (10-12) have been prepared and characterised. On treatment of the 2,6-dipivalate (4) with rabbit serum or partially purified esterase II, PivO-6 was hydrolysed selectively, whereas the 1,6-dipivalate (3) underwent partial 1→2 acyl migration to give 4 and enzymic de-esterification of 3 and 4 occurred simultaneously.
View MoreContact:+44 (0)2036089360-31
Address:Chanceryhouse,Chancery Lan
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Changzhou Ansciep Chemical Co.,Ltd.
Contact:+86 519 8630 5871
Address:A-710 Boan International, 8 East Guangdian Road,Wujin,Changzhou
MedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Doi:10.1016/0040-4039(80)88096-8
(1980)Doi:10.1080/00397919208021347
(1992)Doi:10.1021/jm5008819
(2014)Doi:10.1016/S0040-4039(00)74254-7
(1992)Doi:10.1016/0040-4039(96)01735-2
(1996)Doi:10.1016/S0040-4039(01)00258-1
(2001)